DOWNLOAD PDF

Comprehensive Review of Antiretroviral Therapy Effects on Red Blood Cells in HIV Patients

*Emmanuel Ifeanyi Obeagu1, Getrude Uzoma Obeagu2, Esther Ugo Alum3,4 and Okechukwu Paul-Chima Ugwu4

1Department of Medical Laboratory Science, Kampala International University, Uganda.

2School of Nursing Science, Kampala International University, Uganda.

3Department of Biochemistry, Ebonyi State, Abakaliki, Ebonyi State, Nigeria

4Department of Publication and Extensions, Kampala International University, Uganda.

*Corresponding author: Emmanuel Ifeanyi Obeagu, Department of Medical Laboratory Science, Kampala International University, Uganda.

E-mail: emmanuelobeagu@yahoo.com, obeagu.emmanuel@kiu.ac.ug, 0000-0002-4538-0161

ABSTRACT

Antiretroviral therapy (ART) has revolutionized the landscape of HIV treatment, substantially reducing morbidity and mortality rates in affected individuals. However, while ART effectively suppresses viral replication and restores immune function, its impact on red blood cells (RBCs) and associated hematological parameters has drawn increasing attention in clinical research. This paper aims to provide a comprehensive overview of the effects of ART on RBCs among HIV patients, encompassing alterations in RBC indices, hemoglobin levels, and potential clinical implications. A systematic review of literature and clinical studies was conducted to analyze observed changes in RBC parameters in individuals receiving ART. The clinical implications arising from ART-induced changes in RBCs, particularly the occurrence of anemia and erythrocyte disorders, highlight the importance of vigilant monitoring and tailored management strategies. Addressing these hematological complications is pivotal for optimizing treatment outcomes and enhancing patient well-being. In conclusion, while ART has significantly improved HIV management, its effects on RBCs signify the need for tailored monitoring and interventions to manage hematological complications effectively.

Keywords: Antiretroviral Therapy, Red Blood Cells, HIV

INTRODUCTION

Antiretroviral therapy (ART) has been a groundbreaking cornerstone in the management of Human Immunodeficiency Virus (HIV) infection, transforming it from a once-debilitating condition to a chronic, manageable disease. While the efficacy of ART in suppressing viral replication and restoring immune function is well-established, its impact on red blood cells (RBCs) and related hematological parameters in individuals living with HIV has become an area of increasing interest and clinical relevance [1-10]. Hematological alterations, particularly changes in RBC indices such as mean corpuscular volume (MCV), hemoglobin levels, and hematocrit, have been observed in HIV patients receiving ART. Understanding these changes and their potential implications for patient health, treatment outcomes, and overall well-being is vital for optimizing HIV management strategies [11-16].

Effects of ART on Red Blood Cells

Antiretroviral therapy (ART), the cornerstone of HIV treatment, has significantly improved the prognosis and quality of life for individuals living with HIV. However, the effects of ART on red blood cells (RBCs) have garnered attention due to their potential implications for hematological parameters and overall health in HIV patients [17-22]. Studies have documented changes in RBC indices among individuals undergoing ART. Variations in mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC) have been reported in patients on different ART regimens. These alterations in RBC indices signify potential modifications in RBC morphology and size [23-29]. ART-induced changes in RBC parameters may contribute to alterations in hematological profiles, including decreased hemoglobin levels and hematocrit. These changes, particularly the occurrence of anemia, have been observed in some HIV patients receiving long-term ART [30-35]. The mechanisms underlying ART-associated alterations in RBCs remain multifaceted. Drug-related toxicities, particularly certain antiretroviral medications known to impact erythropoiesis, may contribute to hematological changes. Additionally, the restoration of immune function and viral suppression achieved through ART might indirectly influence RBC parameters [36-41]. Understanding the impact of ART on RBCs holds clinical significance. Hematological changes, such as anemia or alterations in RBC indices, can affect treatment outcomes, patient well-being, and potentially even the progression of the HIV disease itself. Monitoring RBC parameters becomes crucial in managing the comprehensive health of individuals undergoing ART.

Clinical Implications and Hematological Considerations

The clinical implications of ART-induced alterations in red blood cells (RBCs) among individuals living with Human Immunodeficiency Virus (HIV) extend beyond mere hematological changes. Understanding these implications and considering hematological considerations is crucial in managing the comprehensive health and well-being of patients undergoing antiretroviral therapy [42-46]. Alterations in RBC parameters, such as decreased hemoglobin levels and changes in mean corpuscular volume (MCV), may contribute to the development of anemia in HIV patients on long-term ART. Anemia can adversely affect patients’ quality of life, leading to fatigue, decreased exercise tolerance, and reduced overall well-being [47-52]. Hematological changes induced by ART may impact treatment outcomes. Anemia, in particular, might affect the tolerability and efficacy of antiretroviral medications, potentially influencing adherence to treatment regimens and overall therapeutic success [53-58]. The presence of anemia or alterations in RBC parameters could potentially serve as markers for disease progression or severity in HIV-infected individuals. Monitoring these hematological changes might offer insights into the progression of the disease and its impact on patient health [59-64]. Recognizing the hematological implications of ART in HIV patients necessitates tailored management strategies. Close monitoring of RBC indices and hemoglobin levels is imperative to identify and manage hematological complications promptly. Adjustments in treatment regimens or supplementation may be required to address anemia or other erythrocyte disorders [65-71]. Hematological alterations, especially anemia, can significantly impact patients’ quality of life. Fatigue and reduced physical endurance associated with anemia may affect daily activities and overall well-being. Addressing hematological complications is crucial to improving patients’ quality of life.

Implications for Health Policy Makers

The implications of understanding the effects of antiretroviral therapy (ART) on red blood cells (RBCs) among individuals with Human Immunodeficiency Virus (HIV) have substantial relevance for health policy makers in shaping strategies for HIV management and healthcare delivery. Here are some key implications:

Guidelines and Monitoring Protocols: Health policy makers can utilize insights from research on ART-induced changes in RBC parameters to inform the development or updating of guidelines for HIV treatment. Establishing standardized protocols for monitoring hematological parameters, including RBC indices, could be incorporated into routine clinical care.

Resource Allocation and Healthcare Planning: Understanding the hematological implications of ART aids in resource allocation and healthcare planning. Health systems can anticipate the need for specific monitoring tools, laboratory tests, and specialized interventions to manage potential hematological complications among HIV patients on long-term ART.

Treatment Access and Equity: Policies aimed at ensuring equitable access to ART must consider the potential hematological impacts of different antiretroviral regimens. Policymakers can advocate for access to a variety of ART options, considering their hematological profiles, especially for populations with specific risk factors or vulnerabilities.

Integrated Care Models: Integrating hematological monitoring as part of comprehensive HIV care models can be endorsed in policies. Encouraging multidisciplinary collaboration between hematologists, infectious disease specialists, and primary care providers facilitates holistic care for HIV patients, addressing both viral suppression and hematological health.

Long-Term Health Outcomes: Policies focused on long-term health outcomes for HIV patients should encompass the impact of ART on RBCs. Health policy makers can prioritize research funding and initiatives aimed at elucidating the long-term implications of ART-induced hematological changes on patient health and well-being.

Education and Awareness Programs: Policies promoting educational initiatives can inform healthcare providers and patients about the potential hematological effects of ART. Enhancing awareness and understanding of these effects can lead to proactive monitoring, early intervention, and improved patient outcomes.

Data Collection and Research Initiatives: Health policy makers can support initiatives that promote comprehensive data collection on hematological changes in HIV patients receiving ART. Investing in research and surveillance programs facilitates a deeper understanding of the real-world impacts of ART on RBCs and guides evidence-based policymaking.

CONCLUSION

In conclusion, the exploration of the effects of antiretroviral therapy (ART) on red blood cells (RBCs) among individuals living with Human Immunodeficiency Virus (HIV) underscores the intricate interplay between treatment strategies and hematological parameters. Understanding these interactions is paramount in optimizing patient care, treatment outcomes, and overall well-being in the context of HIV management. ART has undoubtedly transformed HIV from a life-threatening disease to a chronic, manageable condition, significantly improving patient survival and quality of life. However, the impact of ART on RBCs, as evidenced by alterations in hematological parameters such as RBC indices and hemoglobin levels, presents both clinical considerations and areas for further investigation. In essence, fostering a deeper understanding of the effects of ART on RBCs is pivotal for optimizing treatment strategies, minimizing hematological complications, and advancing patient-centered care paradigms in the realm of HIV management. This knowledge serves as a cornerstone in guiding evidence-based practices, policies, and interventions aimed at improving the health outcomes and quality of life for individuals living with HIV undergoing antiretroviral therapy.

REFERENCES

  1. Chinedu K, Takim AE, Obeagu EI, Chinazor UD, Eloghosa O, Ojong OE, Odunze U. HIV and TB co-infection among patients who used Directly Observed Treatment Short-course centres in Yenagoa, Nigeria. IOSR J Pharm Biol Sci. 2017;12(4):70-5.
  2. Offie DC, Obeagu EI, Akueshi C, Njab JE, Ekanem EE, Dike PN, Oguh DN. Facilitators and barriers to retention in HIV care among HIV infected MSM attending Community Health Center Yaba, Lagos Nigeria. Journal of Pharmaceutical Research International. 2021;33(52B):10-9.
  3. Nwovu AI, Ifeanyi OE, Uzoma OG, Nwebonyi NS. Occurrence of Some Blood Borne Viral Infection and Adherence to Universal Precautions among Laboratory Staff in Federal Teaching Hospital Abakaliki Ebonyi State. Arch Blood Transfus Disord. 2018;1(2).
  4. Ifeanyi OE, Uzoma OG, Stella EI, Chinedum OK, Abum SC. Vitamin D and insulin resistance in HIV sero positive individuals in Umudike. Int. J. Curr. Res. Med. Sci. 2018;4(2):104-8.
  5. Ifeanyi OE, Leticia OI, Nwosu D, Chinedum OK. A Review on blood borne viral infections: universal precautions. Int. J. Adv. Res. Biol. Sci. 2018;5(6):60-6.
  6. Obeagu EI, Obarezi TN, Omeh YN, Okoro NK, Eze OB. Assessment of some haematological and biochemical parametrs in HIV patients before receiving treatment in Aba, Abia State, Nigeria. Res J Pharma Biol Chem Sci. 2014; 5:825-30.
  7. Obeagu EI, Obarezi TN, Ogbuabor BN, Anaebo QB, Eze GC. Pattern of total white blood cell and differential count values in HIV positive patients receiving treatment in Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria. International Journal of Life Science, Biotechnology and Pharama Research. 2014; 391:186-9.
  8. Obeagu EI. A Review of Challenges and Coping Strategies Faced by HIV/AIDS Discordant Couples. Madonna University journal of Medicine and Health Sciences ISSN: 2814-3035. 2023; 3 (1): 7-12.
  9. Oloro OH, Obeagu EI. A Systematic Review on Some Coagulation Profile in HIV Infection. International Journal of Innovative and Applied Research. 2022;10(5):1-1.
  10. Nwosu DC, Obeagu EI, Nkwuocha BC, Nwanna CA, Nwanjo HU, Amadike JN, Ezemma MC, Okpomeshine EA, Ozims SJ, Agu GC. Alterations in superoxide dismutiase, vitamins C and E in HIV infected children in Umuahia, Abia state. International Journal of Advanced Research in Biological Sciences. 2015;2(11):268-71.
  11. Duguma N, Tesfaye Kiya G, Adissu Maleko W, Bimerew LG. Hematological parameters abnormalities and associated factors in HIV-positive adults before and after highly active antiretroviral treatment in Goba Referral Hospital, southeast Ethiopia: a cross-sectional study. SAGE Open Medicine. 2021; 9:20503121211020175.
  12. Obeagu EI, Malot S, Obeagu GU, Ugwu OP. HIV resistance in patients with Sickle Cell Anaemia. NEWPORT INTERNATIONAL JOURNAL OF SCIENTIFIC AND EXPERIMENTAL SCIENCES (NIJSES). 2023;3(2):56-9.
  13. Ifeanyi OE, Obeagu GU. The Values of CD4 Count, among HIV Positive Patients in FMC Owerri. Int. J. Curr. Microbiol. App. Sci. 2015;4(4):906-10. https://www.academia.edu/download/38320134/Obeagu_Emmanuel_Ifeanyi_and_Obeagu__Getrude_Uzoma.EMMA2.pdf.
  14. Obeagu EI, Okeke EI, Anonde Andrew C. Evaluation of haemoglobin and iron profile study among persons living with HIV in Umuahia, Abia state, Nigeria. Int. J. Curr. Res. Biol. Med. 2016;1(2):1-5.
  15. Alum EU, Ugwu OP, Obeagu EI, Okon MB. Curtailing HIV/AIDS Spread: Impact of Religious Leaders. Newport International Journal of Research in Medical Sciences (NIJRMS). 2023;3(2):28-31.
  16. Obeagu EI, Obeagu GU, Paul-Chima UO. Stigma Associated With HIV. AIDS: A Review. Newport International Journal of Public Health and Pharmacy (Nijpp). 2023;3(2):64-7.
  17. Oguntibeju OO. Quality of life of people living with HIV and AIDS and antiretroviral therapy. HIV/AIDS-Research and Palliative Care. 2012 Aug 6:117-24.
  18. Alum EU, Obeagu EI, Ugwu OP, Aja PM, Okon MB. HIV Infection and Cardiovascular diseases: The obnoxious Duos. Newport International Journal of Research in Medical Sciences (NIJRMS). 2023;3(2):95-9.
  19. Ibebuike JE, Nwokike GI, Nwosu DC, Obeagu EI. A Retrospective Study on Human Immune Deficiency Virus among Pregnant Women Attending Antenatal Clinic in Imo State University Teaching Hospital. International Journal of Medical Science and Dental Research, 2018; 1 (2):08-14. https://www.ijmsdr.org/published%20paper/li1i2/A%20Retrospective%20Study%20on%20Human%20Immune%20Deficiency%20Virus%20among%20Pregnant%20Women%20Attending%20Antenatal%20Clinic%20in%20Imo%20State%20University%20Teaching%20Hospital.pdf.
  20. Obeagu EI, Okwuanaso CB, Edoho SH, Obeagu GU. Under-nutrition among HIV-exposed Uninfected Children: A Review of African Perspective. Madonna University journal of Medicine and Health Sciences. 2022 ;2(3):120-7.
  21. Obeagu EI, Alum EU, Obeagu GU. Factors associated with prevalence of HIV among youths: A review of Africa perspective. Madonna University journal of Medicine and Health Sciences. 2023;3(1):13-8. https://madonnauniversity.edu.ng/journals/index.php/medicine/article/view/93.
  22. Obeagu EI. A Review of Challenges and Coping Strategies Faced by HIV/AIDS Discordant Couples. Madonna University journal of Medicine and Health Sciences. 2023;3(1):7-12. https://madonnauniversity.edu.ng/journals/index.php/medicine/article/view/91.
  23. Naredo E, Möller I, Cruz A, Carmona L, Garrido J. Power Doppler ultrasonographic monitoring of response to anti–tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2008;58(8):2248-56.
  24. Obeagu EI, Obeagu GU. An update on premalignant cervical lesions and cervical cancer screening services among HIV positive women. J Pub Health Nutri. 2023; 6 (2). 2023;141:1-2. links/63e538ed64252375639dd0df/An-update-on-premalignant-cervical-lesions-and-cervical-cancer-screening-services-among-HIV-positive-women.pdf.
  25. Ezeoru VC, Enweani IB, Ochiabuto O, Nwachukwu AC, Ogbonna US, Obeagu EI. Prevalence of Malaria with Anaemia and HIV status in women of reproductive age in Onitsha, Nigeria. Journal of Pharmaceutical Research International. 2021;33(4):10-9.
  26. Omo-Emmanuel UK, Chinedum OK, Obeagu EI. Evaluation of laboratory logistics management information system in HIV/AIDS comprehensive health facilities in Bayelsa State, Nigeria. Int J Curr Res Med Sci. 2017;3(1): 21-38.DOI:22192/ijcrms.2017.03.01.004
  27. Obeagu EI, Obeagu GU, Musiimenta E, Bot YS, Hassan AO. Factors contributing to low utilization of HIV counseling and testing services. Int. J. Curr. Res. Med. Sci. 2023;9(2): 1-5.DOI:22192/ijcrms.2023.09.02.001
  28. Obeagu EI, Obeagu GU. An update on survival of people living with HIV in Nigeria. J Pub Health Nutri. 2022; 5 (6). 2022;129. links/645b4bfcf3512f1cc5885784/An-update-on-survival-of-people-living-with-HIV-in-Nigeria.pdf.
  29. Offie DC, Obeagu EI, Akueshi C, Njab JE, Ekanem EE, Dike PN, Oguh DN. Facilitators and barriers to retention in HIV care among HIV infected MSM attending Community Health Center Yaba, Lagos Nigeria. Journal of Pharmaceutical Research International. 2021;33(52B):10-9.
  30. Quaye O, Kuleape JA, Bonney EY, Puplampu P, Tagoe EA. Imbalance of antioxidant enzymes activities and trace elements levels in Ghanaian HIV-infected patients. PLoS One. 2019;14(7): e0220181.
  31. Obeagu EI, Ogbonna US, Nwachukwu AC, Ochiabuto O, Enweani IB, Ezeoru VC. Prevalence of Malaria with Anaemia and HIV status in women of reproductive age in Onitsha, Nigeria. Journal of Pharmaceutical Research International. 2021;33(4):10-9.
  32. Odo M, Ochei KC, Obeagu EI, Barinaadaa A, Eteng UE, Ikpeme M, Bassey JO, Paul AO. TB Infection Control in TB/HIV Settings in Cross River State, Nigeria: Policy Vs Practice. Journal of Pharmaceutical Research International. 2020;32(22):101-9.
  33. Obeagu EI, Eze VU, Alaeboh EA, Ochei KC. Determination of haematocrit level and iron profile study among persons living with HIV in Umuahia, Abia State, Nigeria. J BioInnovation. 2016;5:464-71. links/592bb4990f7e9b9979a975cf/DETERMINATION-OF-HAEMATOCRIT-LEVEL-AND-IRON-PROFILE-STUDY-AMONG-PERSONS-LIVING-WITH-HIV-IN-UMUAHIA-ABIA-STATE-NIGERIA.pdf.
  34. Ifeanyi OE, Obeagu GU. The values of prothrombin time among HIV positive patients in FMC owerri. International Journal of Current Microbiology and Applied Sciences. 2015;4(4):911-6. https://www.academia.edu/download/38320140/Obeagu_Emmanuel_Ifeanyi_and_Obeagu__Getrude_Uzoma2.EMMA1.pdf.
  35. Izuchukwu IF, Ozims SJ, Agu GC, Obeagu EI, Onu I, Amah H, Nwosu DC, Nwanjo HU, Edward A, Arunsi MO. Knowledge of preventive measures and management of HIV/AIDS victims among parents in Umuna Orlu community of Imo state Nigeria. Int. J. Adv. Res. Biol. Sci. 2016;3(10): 55-65.DOI;22192/ijarbs.2016.03.10.009
  36. Zhang M, Wang C, Oberstaller J, Thomas P, Otto TD, Casandra D, Boyapalle S, Adapa SR, Xu S, Button-Simons K, Mayho M. The apicoplast link to fever-survival and artemisinin-resistance in the malaria parasite. Nature communications. 2021 ;12(1):4563.
  37. Chinedu K, Takim AE, Obeagu EI, Chinazor UD, Eloghosa O, Ojong OE, Odunze U. HIV and TB co-infection among patients who used Directly Observed Treatment Short-course centres in Yenagoa, Nigeria. IOSR J Pharm Biol Sci. 2017;12(4):70-5. links/5988ab6d0f7e9b6c8539f73d/HIV-and-TB-co-infection-among-patients-who-used-Directly-Observed-Treatment-Short-course-centres-in-Yenagoa-Nigeria.pdf
  38. Oloro OH, Oke TO, Obeagu EI. Evaluation of Coagulation Profile Patients with Pulmonary Tuberculosis and Human Immunodeficiency Virus in Owo, Ondo State, Nigeria. Madonna University journal of Medicine and Health Sciences. 2022;2(3):110-9.
  39. Nwosu DC, Obeagu EI, Nkwocha BC, Nwanna CA, Nwanjo HU, Amadike JN, Elendu HN, Ofoedeme CN, Ozims SJ, Nwankpa P. Change in Lipid Peroxidation Marker (MDA) and Non enzymatic Antioxidants (VIT C & E) in HIV Seropositive Children in an Urban Community of Abia State. Nigeria. J. Bio. Innov. 2016;5(1):24-30. links/5ae735e9a6fdcc5b33eb8d6a/CHANGE-IN-LIPID-PEROXIDATION-MARKER-MDAAND-NON-ENZYMATIC-ANTIOXIDANTS-VIT-C-E-IN-HIV-SEROPOSITIVE-CHILDREN-IN-AN-URBAN-COMMUNITY-OF-ABIA-STATE-NIGERIA.pdf.
  40. Igwe CM, Obeagu IE, Ogbuabor OA. Clinical characteristics of people living with HIV/AIDS on ART in 2014 at tertiary health institutions in Enugu, Nigeria. J Pub Health Nutri. 2022; 5 (6). 2022;130. links/645a166f5762c95ac3817d32/Clinical-characteristics-of-people-living-with-HIV-AIDS-on-ART-in-2014-at-tertiary-health-institutions-in-Enugu.pdf.
  41. Ifeanyi OE, Obeagu GU, Ijeoma FO, Chioma UI. The values of activated partial thromboplastin time (APTT) among HIV positive patients in FMC Owerri. Int J Curr Res Aca Rev. 2015; 3:139-44. https://www.academia.edu/download/38320159/Obeagu_Emmanuel_Ifeanyi3__et_al.IJCRAR.pdf.
  42. Mulaudzi MB, Woods JF, Venter WD, van Vuuren C, van der Plas H, Stead D, Rassool MS, Preiser W, Nkonyane TC, Nash J, Moorhouse M. Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update. Southern African Journal of HIV Medicine. 2020;21(1).
  43. Obiomah CF, Obeagu EI, Ochei KC, Swem CA, Amachukwu BO. Hematological indices o HIV seropositive subjects in Nnamdi Azikiwe University teaching hospital (NAUTH), Nnewi. Ann Clin Lab Res. 2018;6(1):1-4. links/5aa2bb17a6fdccd544b7526e/Haematological-Indices-of-HIV-Seropositive-Subjects-at-Nnamdi-Azikiwe.pdf
  44. Omo-Emmanuel UK, Ochei KC, Osuala EO, Obeagu EI, Onwuasoanya UF. Impact of prevention of mother to child transmission (PMTCT) of HIV on positivity rate in Kafanchan, Nigeria. Int. J. Curr. Res. Med. Sci. 2017;3(2): 28-34.DOI:22192/ijcrms.2017.03.02.005
  45. Aizaz M, Abbas FA, Abbas A, Tabassum S, Obeagu EI. Alarming rise in HIV cases in Pakistan: Challenges and future recommendations at hand. Health Science Reports. 2023;6(8): e1450.
  46. Obeagu EI, Amekpor F, Scott GY. An update of human immunodeficiency virus infection: Bleeding disorders. J Pub Health Nutri. 2023; 6 (1). 2023;139. links/645b4a6c2edb8e5f094d9bd9/An-update-of-human-immunodeficiency-virus-infection-Bleeding.pdf.
  47. Duguma N, Tesfaye Kiya G, Adissu Maleko W, Bimerew LG. Hematological parameters abnormalities and associated factors in HIV-positive adults before and after highly active antiretroviral treatment in Goba Referral Hospital, southeast Ethiopia: a cross-sectional study. SAGE Open Medicine. 2021; 9:20503121211020175.
  48. Obeagu EI, Scott GY, Amekpor F, Ofodile AC, Edoho SH, Ahamefula C. Prevention of New Cases of Human Immunodeficiency Virus: Pragmatic Approaches of Saving Life in Developing Countries. Madonna University journal of Medicine and Health Sciences. 2022 Dec 20;2(3):128-34. https://madonnauniversity.edu.ng/journals/index.php/medicine/article/view/86.
  49. Walter O, Anaebo QB, Obeagu EI, Okoroiwu IL. Evaluation of Activated Partial Thromboplastin Time and Prothrombin Time in HIV and TB Patients in Owerri Metropolis. Journal of Pharmaceutical Research International. 2022:29-34.
  50. Odo M, Ochei KC, Obeagu EI, Barinaadaa A, Eteng EU, Ikpeme M, Bassey JO, Paul AO. Cascade variabilities in TB case finding among people living with HIV and the use of IPT: assessment in three levels of care in cross River State, Nigeria. Journal of Pharmaceutical Research International. 2020;32(24):9-18.
  51. Jakheng SP, Obeagu EI. Seroprevalence of human immunodeficiency virus based on demographic and risk factors among pregnant women attending clinics in Zaria Metropolis, Nigeria. J Pub Health Nutri. 2022; 5 (8). 2022;137. links/6317a6b1acd814437f0ad268/Seroprevalence-of-human-immunodeficiency-virus-based-on-demographic-and-risk-factors-among-pregnant-women-attending-clinics-in-Zaria-Metropolis-Nigeria.pdf.
  52. Obeagu EI, Obeagu GU. A Review of knowledge, attitudes and socio-demographic factors associated with non-adherence to antiretroviral therapy among people living with HIV/AIDS. Int. J. Adv. Res. Biol. Sci. 2023;10(9):135-42.DOI:22192/ijarbs.2023.10.09.015 links/6516faa61e2386049de5e828/A-Review-of-knowledge-attitudes-and-socio-demographic-factors-associated-with-non-adherence-to-antiretroviral-therapy-among-people-living-with-HIV-AIDS.pdf
  53. Hawkins T. Understanding and managing the adverse effects of antiretroviral therapy. Antiviral research. 2010;85(1):201-9.
  54. Obeagu EI, Onuoha EC. Tuberculosis among HIV Patients: A review of Prevalence and Associated Factors. Int. J. Adv. Res. Biol. Sci. 2023;10(9):128-34.DOI:22192/ijarbs.2023.10.09.014 links/6516f938b0df2f20a2f8b0e0/Tuberculosis-among-HIV-Patients-A-review-of-Prevalence-and-Associated-Factors.pdf.
  55. Obeagu EI, Ibeh NC, Nwobodo HA, Ochei KC, Iwegbulam CP. Haematological indices of malaria patients coinfected with HIV in Umuahia. Int. J. Curr. Res. Med. Sci. 2017;3(5):100-4.DOI:22192/ijcrms.2017.03.05.014 https://www.academia.edu/download/54317126/Haematological_indices_of_malaria_patients_coinfected_with_HIV.pdf
  56. Jakheng SP, Obeagu EI, Abdullahi IO, Jakheng EW, Chukwueze CM, Eze GC, Essien UC, Madekwe CC, Madekwe CC, Vidya S, Kumar S. Distribution Rate of Chlamydial Infection According to Demographic Factors among Pregnant Women Attending Clinics in Zaria Metropolis, Kaduna State, Nigeria. South Asian Journal of Research in Microbiology. 2022;13(2):26-31.
  57. Viola N, Kimono E, Nuruh N, Obeagu EI. Factors Hindering Elimination of Mother to Child Transmission of HIV Service Uptake among HIV Positive Women at Comboni Hospital Kyamuhunga Bushenyi District. Asian Journal of Dental and Health Sciences. 2023 ;3(2):7-14. http://ajdhs.com/index.php/journal/article/view/39.
  58. Okorie HM, Obeagu Emmanuel I, Okpoli Henry CH, Chukwu Stella N. Comparative study of enzyme linked immunosorbent assay (Elisa) and rapid test screening methods on HIV, Hbsag, Hcv and Syphilis among voluntary donors in. Owerri, Nigeria. J Clin Commun Med. 2020;2(3):180-83.DOI: DOI: 32474/JCCM.2020.02.000137 links/5f344530458515b7291bd95f/Comparative-Study-of-Enzyme-Linked-Immunosorbent-Assay-ElISA-and-Rapid-Test-Screening-Methods-on-HIV-HBsAg-HCV-and-Syphilis-among-Voluntary-Donors-in-Owerri-Nigeria.pdf.
  59. Kallianpur AR, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre SL, Ellis RJ, Heaton RK, Franklin DR, Barnholtz-Sloan J, Collier AC. Anemia and red blood cell indices predict HIV-associated neurocognitive impairment in the highly active antiretroviral therapy era. The Journal of infectious diseases. 2016;213(7):1065-73.
  60. Ezugwu UM, Onyenekwe CC, Ukibe NR, Ahaneku JE, Onah CE, Obeagu EI, Emeje PI, Awalu JC, Igbokwe GE. Use of ATP, GTP, ADP and AMP as an Index of Energy Utilization and Storage in HIV Infected Individuals at NAUTH, Nigeria: A Longitudinal, Prospective, Case-Controlled Study. Journal of Pharmaceutical Research International. 2021;33(47A):78-84.
  61. Emannuel G, Martin O, Peter OS, Obeagu EI, Daniel K. Factors Influencing Early Neonatal Adverse Outcomes among Women with HIV with Post Dated Pregnancies Delivering at Kampala International University Teaching Hospital, Uganda. Asian Journal of Pregnancy and Childbirth. 2023;6(1):203-11. http://research.sdpublishers.net/id/eprint/2819/.
  62. Igwe MC, Obeagu EI, Ogbuabor AO, Eze GC, Ikpenwa JN, Eze-Steven PE. Socio-Demographic Variables of People Living with HIV/AIDS Initiated on ART in 2014 at Tertiary Health Institution in Enugu State. Asian Journal of Research in Infectious Diseases. 2022;10(4):1-7.
  63. Vincent CC, Obeagu EI, Agu IS, Ukeagu NC, Onyekachi-Chigbu AC. Adherence to Antiretroviral Therapy among HIV/AIDS in Federal Medical Centre, Owerri. Journal of Pharmaceutical Research International. 2021;33(57A):360-8.
  64. Igwe MC, Obeagu EI, Ogbuabor AO. Analysis of the Factors and Predictors of Adherence to Healthcare of People Living with HIV/AIDS in Tertiary Health Institutions in Enugu State. Madonna University journal of Medicine and Health Sciences. 2022;2(3):42-57. https://madonnauniversity.edu.ng/journals/index.php/medicine/article/view/75.
  65. Madekwe CC, Madekwe CC, Obeagu EI. Inequality of monitoring in Human Immunodeficiency Virus, Tuberculosis and Malaria: A Review. Madonna University journal of Medicine and Health Sciences ISSN: 2814-3035. 2022;2(3):6-15. https://madonnauniversity.edu.ng/journals/index.php/medicine/article/view/69
  66. Echendu GE, Vincent CC, Ibebuike J, Asodike M, Naze N, Chinedu EP, Ohale B, Obeagu EI. Weights Of Infants Born to HIV Infected Mothers: A Prospective Cohort Study in Federal Medical Centre, Owerri, Imo State. European Journal of Pharmaceutical and Medical Research, 2023; 10(8): 564-568
  67. Nwosu DC, Nwanjo HU, Okolie NJ, Ikeh K, Ajero CM, Dike J, Ojiegbe GC, Oze GO, Obeagu EI, Nnatunanya I, Azuonwu O. Biochemical Alterations in Adult HIV Patients on Antiretrqviral Therapy. World Journal of Pharmacy and Pharmaceutical Sciences, 2015; 4(3):153-160. links/5a4fd0500f7e9bbc10526b38/BIOCHEMICAL-ALTERATIONS-IN-ADULT-HIV-PATIENTS-ON-ANTIRETRQVIRAL-THERAPY.pdf.
  68. Obeagu EI, Obeagu GU. Effect of CD4 Counts on Coagulation Parameters among HIV Positive Patients in Federal Medical Centre, Owerri, Nigeria. Int. J. Curr. Res. Biosci. Plant Biol. 2015;2(4):45-9.
  69. Obeagu EI, Nwosu DC. Adverse drug reactions in HIV/AIDS patients on highly active antiretro viral therapy: a review of prevalence. Int. J. Curr. Res. Chem. Pharm. Sci. 2019;6(12):45-8.DOI:22192/ijcrcps.2019.06.12.004 links/650aba1582f01628f0335795/Adverse-drug-reactions-in-HIV-AIDS-patients-on-highly-active-antiretro-viral-therapy-a-review-of-prevalence.pdf.
  70. Obeagu EI, Scott GY, Amekpor F, Obeagu GU. Implications of CD4/CD8 ratios in Human Immunodeficiency Virus infections. Int. J. Curr. Res. Med. Sci. 2023;9(2):6-13.DOI:22192/ijcrms.2023.09.02.002 links/645a4a462edb8e5f094ad37c/Implications-of-CD4-CD8-ratios-in-Human-Immunodeficiency-Virus-infections.pdf.
  71. Obeagu EI, Ochei KC, Okeke EI, Anode AC. Assessment of the level of haemoglobin and erythropoietin in persons living with HIV in Umuahia. Int. J. Curr. Res. Med. Sci. 2016;2(4):29-33. links/5711c47508aeebe07c02496b/Assessment-of-the-level-of-haemoglobin-and-erythropoietin-in-persons-living-with-HIV-in-Umuahia.pdf.

CITE AS: Emmanuel Ifeanyi Obeagu, Getrude Uzoma Obeagu, Esther Ugo Alum and Okechukwu Paul-Chima Ugwu (2023). Comprehensive Review of Antiretroviral Therapy Effects on Red Blood Cells in HIV Patients. INOSR Experimental Sciences 12(3):63-72. https://doi.org/10.59298/INOSRES/2023/6.3.21322

DOWNLOAD PDF